ArticleThoracic cancer2020

Activation of insulin-like growth factor-1 receptor confers acquired resistance to osimertinib in non-small cell lung cancer with EGFR T790M mutation.

Daisuke Hayakawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.